Abivax S.A.
ABVX
Rang în acțiuni
#2352
Abivax S.A. is a Paris-based pharmaceutical firm, established in 2013,... Abivax S.A. is a Paris-based pharmaceutical firm, established in 2013, dedicated to identifying and refining treatments for various serious conditions, including inflammatory and infectious diseases, as well as cancer. Its primary drug candidate, ABX464, is currently undergoing Phase IIb clinical trials for ulcerative colitis, Crohn's disease, and COVID-19, and is in Phase IIa trials for rheumatoid arthritis. This compound has also successfully completed a Phase IIa study focused on achieving viral remission in HIV patients. Additionally, the company is advancing ABX 196, an immune-enhancing agent, through Phase 1/2 clinical trials for hepatocellular cancer. Beyond these main programs, Abivax is also engaged in research initiatives targeting Dengue fever, influenza, and the respiratory syncytial virus. The company holds significant licensing agreements with esteemed institutions such as the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie.
Preț acțiune
$95.29
Ultima sincronizare: 2026-10-21
Capitalizare de piață
$8.32B
Schimbare (1 zi)
-3.50%
Schimbare (1 an)
7.83%
Țară
FR
Tranzacționează Abivax S.A. (ABVX)
Categorie
Healthcare
Istoricul spliturilor pentru Abivax S.A. (ABVX)
Acțiunea Abivax S.A. (simbol: ABVX) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Oct 22, 2026.
O acțiune ABVX cumpărată înainte de Oct 22, 2026 este echivalentă astăzi cu 0 acțiuni ABVX.
Cel mai recent split a avut loc pe Oct 22, 2026.
O acțiune ABVX cumpărată înainte de Oct 22, 2026 este echivalentă astăzi cu 0 acțiuni ABVX.
Listă splituri acțiuni
| An | Split | Multiplu | Multiplu cumulativ |
|---|---|---|---|
| Nu sunt suficiente date pentru perioada selectată. | |||
Splituri pentru companii similare sau competitori
| Companie | Număr total de splituri | Multiplu cumulativ | Țara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|